Lipid Metabolism Emerges as a Central Driver of Drug Resistance in Aggressive Lymphoma
A new review argues that lipid metabolic reprogramming acts as a convergence node for treatment resistance in aggressive non-Hodgkin lymphoma, ...
A new review argues that lipid metabolic reprogramming acts as a convergence node for treatment resistance in aggressive non-Hodgkin lymphoma, ...
Genomic analysis of nearly 2,000 dogs reveals that they carry the same cereblon variation that makes mice insensitive to thalidomide, ...
Researchers report that the osteoarthritis drug diacerein kills glioma cells by triggering caspase-3 and GSDME-mediated pyroptosis, revealing a new drug-repurposing ...
A major new review finds that symptomatic therapies for Alzheimer disease, from cholinesterase inhibitors to personalized psychosocial care, deliver meaningful ...
Egyptian researchers found that the alcohol-aversion drug disulfiram synergizes with fluconazole, downregulates the Cdr1 efflux pump, and inhibits biofilm formation ...
Researchers found that the RNA acetyltransferase NAT10 helps glioblastoma resist radiotherapy by stabilizing SLC7A11 mRNA and blocking immunogenic ferroptosis, and ...
A new review synthesizes decades of evidence showing that selective COX-2 inhibitors can suppress tumor initiation, growth and immunotherapy resistance ...
Recent research involving health data from over 130 million individuals has uncovered a promising link between the use of certain ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine